1,193 Spam-Free Article(s) Found
Sort:
Like
Filter:
All
Symbol Name Last Close Mkt Cap DailyStocks'
Rating
Our DailyStocks’ Rating System is a proprietary algorithm that combines the vote of the investor community and legendary trader Richard Dennis’ Turtle Trader System and the System Rules of the Turtle Traders Each day, we generate Buy, Sell, Uptrend or Downtrend signals for 3000 Stocks in the U.S. Markets.
Vote Now!
Monday’s Close
ONCE Spark Therapeutics, Inc. $57.05 $2.14B N/A
Article Searches
Roche Extends Offer Period for Spark Therapeutics Acquisition http://www.zacks.com/stock/news/370066/roche-extends-offer-period-for-spark-therapeutics-acquisition?cid=CS-ZC-FT-370066 Apr 03, 2019 - Roche (RHHBY) withdraws its Premerger Notification and Report Form in connection with the pending acquisition of Spark Therapeutics.
Sangamo Rises on Positive Phase I/II Hemophilia Study Data http://www.zacks.com/stock/news/370133/sangamo-rises-on-positive-phase-i-ii-hemophilia-study-data?cid=CS-ZC-FT-370133 Apr 03, 2019 - Sangamo (SGMO) and partner Pfizer announce encouraging data from a phase I/II study evaluating their gene therapy candidate for treating hemophilia A.
Roche's (RHHBY) Q1 Sales Strong on Solid Demand for New Drugs http://www.zacks.com/stock/news/386875/roches-rhhby-q1-sales-strong-on-solid-demand-for-new-drugs?cid=CS-ZC-FT-386875 Apr 18, 2019 - Roche's (RHHBY) performance in the first quarter of 2019 is driven by solid strength of new drugs, which more than offset competition from biosimilars.

Pages: 1...115116117118119120

<<<Page 120